Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests as well as the accuracy of drug delivery for infectious diseases and oncology.
Coronavirus Update - Our team is available
In view of the spread of Covid-19 (coronavirus) in our country and across the world, our topmost priority is the health and safety of all our customers and employees. Our team will be available and the best way to reach us at this time is via email: email@example.com
IPVC 2020 - Postponed to July 20-24
Novosanis will be attending the virtual International Papillomavirus Conference from July 20 to 24. IPVC 2020 will gather researchers, clinicians and other health professionals to share knowledge and ideas on papillomaviruses and its associated diseases.